AI-generated summary
The authors report two randomized controlled trials of high-fluence red light emitting diode therapy on healthy adults' forearm skin, comparing active light with mock irradiation. Dose-limiting adverse events such as blistering and prolonged erythema occurred only at the highest fluences, and no serious adverse events were reported. The authors conclude the light was safe up to 320 J/cm2 for skin of color and 480 J/cm2 for non-Hispanic Caucasian participants.
- Who or what was studied
- Healthy adult human subjects, including skin of color and non-Hispanic Caucasian individuals, in two phase I trials (STARS 1 and STARS 2)
- Limits stated in the abstract
- The abstract describes phase I single-blind dose escalation trials in healthy subjects, so the findings address short-term safety rather than clinical efficacy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 160 J/cm2, 640 J/cm2, 480 J/cm2, 320 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Dose, Fluence, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.